Preprint / Version 1

Base Editing: Advancements and the Future of Gene Therapy


  • Aditi Chatterjee



Base Editing, Gene Therapy


The work done on CRISPR-Cas9 has pioneered the way for base editing, a technology that utilizes RNA-guided nucleases and other components of CRISPR systems along with a specific deaminase that can convert a C base to a T base, or a G to an A. Base editing focuses particularly on converting point mutations, which lead to the majority of human genetically linked diseases. After the conversion from a problematic gene, the DNA sequence is changed, effectively changing the genome’s identity. This research paper focuses on advantages and current applications of base editing using laboratory based and therapeutics based research, along with highlighting current drawbacks and future theoretical applications of the technology

References or Bibliography

[HL19] Kevin T. Zhao Shannon M. Miller Nicole M. Gaudelli Benjamin

L. Oakes Christof Fellmann David F. Savage Huang, Tony P. and

David R. Liu. Circularly permuted and pam-modified cas9 variants

broaden the targeting scope of base editors. Nature Biotechnology,

[KJ15] Michelle S. Prew Shengdar Q. Tsai Ved V. Topkar Nhu T. Nguyen

Zongli Zheng Andrew P.W. Gonzales Zhuyun Li Randall T. Peterson

Jing-Ruey Joanna Yeh Martin J. Aryee Kleinstiver, Benjamin P. and

J. Keith Joung. Engineered crispr-cas9 nucleases with altered pam

specificities. Nature, 2015.

[KL16] Yongjoo B. Kim Michael S. Packer John A. Zuris Komor, Alexis C.

and David R. Liu. Programmable editing of a target base in genomic

dna without double-stranded dna cleavage. Nature, 2016.

[LL17] Yajing Liu Yanting Zeng Jianan Li Lijie Wang Guang Yang Dunjin Chen Xiaoyun Shang Jia Chen Xingxu Huang Li, Guanglei and

Jianqiao Liu. Highly efficient and precise base editing in discarded

human tripronuclear embryos. Protein Cell, 2017.

[RL18] Holly A. Rees and David R. Liu. Base editing: precision chemistry

on the genome and transcriptome of living cells. Nature Reviews

Genetics, 2018.

[The19] Beam Therapeutics. Beam therapeutics presents data on multiplex

base editing for engineered car-t cells at american society of gene and

cell therapy 22nd annual meeting. 2019.

[WM19] Cara-lin Lonetree Mitchell G. Kluesner Matthew J. Johnson Emily

J. Pomeroy Miechaleen D. Diers Walker S. Lahr Garrett M. Draper

Nicholas J. Slipek Branden A. Smeester Klaus N. Lovendahl Amber

N. McElroy Wendy R. Gordon Mark J. Osborn Webber, Beau R.

and Branden S. Moriarity. Highly efficient multiplex human t cell

engineering without double-strand breaks using cas9 base editors.

Nature Communications, 2019.

[ZH18] Jianan Li-Guanglei Li Shisheng Huang Wenxia Yu Yu Zhang Dunjin

Chen Jia Chen Jianqiao Liu Zeng, Yanting and Xingxu Huang. Correction of the marfan syndrome pathogenic fbn1 mutation by base

editing in human cells and heterozygous embryos. Molecular Therapy, 2018